Scott Weaver to Disease Models, Animal
This is a "connection" page, showing publications Scott Weaver has written about Disease Models, Animal.
Connection Strength
0.303
-
Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule. Viruses. 2019 08 31; 11(9).
Score: 0.055
-
Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates. J Infect Dis. 2019 07 31; 220(5):735-742.
Score: 0.055
-
Viral Retinopathy in Experimental Models of Zika Infection. Invest Ophthalmol Vis Sci. 2017 08 01; 58(10):4355–4365.
Score: 0.048
-
Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential. Antiviral Res. 2017 07; 143:246-251.
Score: 0.047
-
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol. 2017 04 15; 91(8).
Score: 0.046
-
Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
Score: 0.015
-
ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques. Viruses. 2018 11 21; 10(11).
Score: 0.013
-
A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine. 2018 06 22; 36(27):3894-3900.
Score: 0.013
-
African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo. Am J Trop Med Hyg. 2018 02; 98(2):432-444.
Score: 0.012